Blood–brain barrier dysfunction in parkinsonian midbrain in vivo

R Kortekaas, KL Leenders… - Annals of …, 2005 - Wiley Online Library
… uptake of [ 11 C]-verapamil, which is normally extruded from the brainmidbrain of PD patients
relative to controls. This is the first evidence supporting a dysfunctional blood–brain barrier

Decreased blood–brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA

AL Bartels, ATM Willemsen, R Kortekaas… - Journal of neural …, 2008 - Springer
… We did not find changed P-gp function in the cerebellum in the MSA patients. However, the
MSA patients in this study did not show symptoms of cerebellar dysfunction and MRI scans …

Striatal blood–brain barrier permeability in Parkinson's disease

MT Gray, JM Woulfe - Journal of Cerebral Blood Flow & …, 2015 - journals.sagepub.com
… that blood–brain barrier (BBB) dysfunction is involved in the course of Parkinson's disease
(PD… In humans, PD BBB integrity has previously been assessed in the midbrain. Extravascular …

Blood–brain barrier leakage is increased in Parkinson's disease

S Al-Bachari, JH Naish, GJM Parker… - Frontiers in …, 2020 - frontiersin.org
Background Blood–brain barrier (BBB) disruption has been noted in animal models of
Parkinson’s disease (PD) and forms the basis of the vascular hypothesis of neurodegeneration, …

Astrocytic VEGFA: An essential mediator in blood–brainbarrier disruption in Parkinson's disease

G Lan, P Wang, RB Chan, Z Liu, Z Yu, X Liu, Y Yang… - Glia, 2022 - Wiley Online Library
… To investigate the possibility of BBB dysfunction in PD, we started with examining the …
with Parkinson's disease. (a) Representative immunofluorescence images of midbrain from …

Blood–brain barrier P-glycoprotein function is not impaired in early Parkinson's disease

AL Bartels, BNM Van Berckel, M Lubberink… - Parkinsonism & related …, 2008 - Elsevier
brain, over time damaging sensitive neuronal cells eg dopamine neurons in the
mesencephalon… is important as an inhibiting factor of brain penetration of exogenic substances. …

New blood–brain barrier models using primary Parkinson's Disease rat brain endothelial cells and astrocytes for the development of central nervous system drug …

P Cai, Y Zheng, Y Sun, C Zhang… - ACS Chemical …, 2021 - ACS Publications
… transporter function in the midbrain, which suggested that an impaired BBB causes or
accelerates PD progression. (12) Developing an appreciation of BBB dysfunction in PD will not …

Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease

R Cabezas, M Ávila, J Gonzalez… - Frontiers in cellular …, 2014 - frontiersin.org
… In this review we discuss the implications of astrocyte functions in the protection of the BBB,
and in the development of Parkinson’s disease (PD) and related disorders. Additionally, we …

… blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's …

YX Chao, BP He, SSW Tay - Journal of neuroimmunology, 2009 - Elsevier
Parkinson's disease (PD) is a common neurodegenerative disorder in aged people. … liver
and MBL infiltration into to the midbrain are relevant to Parkinson's disease. In addition, the role …

Striatal blood–brain barrier opening in Parkinson's disease dementia: a pilot exploratory study

JA Pineda‐Pardo, C Gasca‐Salas… - … Disorders, 2022 - Wiley Online Library
… The clinical exam at baseline and 3-month follow-up visits comprised the MDS-UPDRS (Movement
Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale…